JUBILANT PHARMOVA
Back to Income Statement
|
JUBILANT PHARMOVA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹839 Cr | ₹77 Cr | ₹-61 Cr | ₹414 Cr | ₹836 Cr |
What is the latest Consolidated Net Profit of JUBILANT PHARMOVA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹839 Cr |
| Mar2024 | ₹77 Cr |
| Mar2023 | ₹-61 Cr |
| Mar2022 | ₹414 Cr |
| Mar2021 | ₹836 Cr |
How is Consolidated Net Profit of JUBILANT PHARMOVA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹839 Cr | 988.72 | |
| Mar2024 | ₹77 Cr | Positive | |
| Mar2023 | ₹-61 Cr | Negative | |
| Mar2022 | ₹414 Cr | -50.48 | |
| Mar2021 | ₹836 Cr | - | |
Compare Consolidated Net Profit of peers of JUBILANT PHARMOVA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JUBILANT PHARMOVA | ₹15,207.6 Cr | -3.9% | -11.6% | -1.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
JUBILANT PHARMOVA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JUBILANT PHARMOVA | -3.9% |
-11.6% |
-1.6% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses